A Study of C-CAR039 in Subjects With Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma
Clinical trial NCT05149391 · COMPLETED
Trial details
- NCT number
- NCT05149391
- Sponsor
- Peking University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-20
- Primary completion
- 2024-01-30
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.